Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2026 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| MAR-LEFLUNOMIDE | marcan pharmaceuticals inc | Marketed | Dec 4, 2024 | Marketed |
| M-TRANEXAMIC ACID | mantra pharma inc | Marketed | Dec 3, 2024 | Marketed |
| AYVAKYT | Blueprint Medicines | Marketed | Dec 2, 2024 | Marketed |
| AYVAKYT | Blueprint Medicines | Marketed | Dec 2, 2024 | Marketed |
| AYVAKYT | Blueprint Medicines | Marketed | Dec 2, 2024 | Marketed |
| AYVAKYT | Blueprint Medicines | Marketed | Dec 2, 2024 | Marketed |
| TIE SURFACE CLEANER AND DISINFECTANT | NITMOI LABS INC | Marketed | Nov 29, 2024 | Marketed |
| JAMP IMIPRAMINE | Jamp Pharma Corporation | Marketed | Nov 29, 2024 | Marketed |
| JAMP IMIPRAMINE | Jamp Pharma Corporation | Marketed | Nov 29, 2024 | Marketed |
| JAMP IMIPRAMINE | Jamp Pharma Corporation | Marketed | Nov 29, 2024 | Marketed |
| DESLORATADINE | Jamp Pharma Corporation | Marketed | Nov 29, 2024 | Marketed |
| JAMP IMIPRAMINE | Jamp Pharma Corporation | Marketed | Nov 29, 2024 | Marketed |
| IMDELLTRA | Amgen Canada Inc | Marketed | Nov 28, 2024 | Marketed |
| OPZELURA | 因塞特 | Marketed | Nov 28, 2024 | Marketed |
| IMDELLTRA | Amgen Canada Inc | Marketed | Nov 28, 2024 | Marketed |
| PMS-SITAGLIPTIN | Pharmascience Inc | Marketed | Nov 26, 2024 | Marketed |
| EBGLYSS | eli lilly canada inc | Marketed | Nov 26, 2024 | Marketed |
| PMS-SITAGLIPTIN | Pharmascience Inc | Marketed | Nov 26, 2024 | Marketed |
| PMS-SITAGLIPTIN | Pharmascience Inc | Marketed | Nov 26, 2024 | Marketed |
| TEVA-RIVAROXABAN | teva canada limited | Marketed | Nov 26, 2024 | Marketed |
